CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma.

ABSTRACT:

SUBMITTER: Guo Y 

PROVIDER: S-EPMC9043938 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature